跳至主要内容
临床试验/IRCT20140406017139N3
IRCT20140406017139N3招募中3 期

The effects of oligopin supplementation on inflammatory and metabolic parameters in women with polycystic ovary syndrome.

Alborz University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
Female

入选标准

  • PCOS diagnosis according to Androgen Excess Society criteria: hyperandrogenism (hirsutism) / hyperandrogenemia (testosterone >70ng/dl) and/or oligomenorrhea (<8 spontaneous menses per year) and/or polycystic ovarian morphology on ultrasound
  • Women aged from 18 to 40 years old
  • Normal prolactin
  • normal thyroid function
  • 17-OH progesterone
  • No evidence of Androgenic hormone secretory tumors
  • No Cushing's syndrome or acromegaly

排除标准

  • Using either oral contraceptives or steroids hormones during 1 month before the onset of the trial
  • Using medications that could modify the metabolism during 1 month before the onset of the trial

研究者

发起方
Alborz University of Medical Sciences

相似试验